Literature DB >> 31832272

Animal Models for Studies of Keloid Scarring.

Dorothy M Supp1,2.   

Abstract

Significance: Keloid scarring is a disfiguring fibroproliferative disorder that can significantly impair the quality of life in affected individuals. The mechanisms that initiate keloid scarring are incompletely understood, and keloids remain one of the most challenging skin conditions to treat. Keloids are unique to humans; thus, the lack of adequate animal models has hindered research efforts aimed at prevention and effective therapeutic intervention. Recent Advances: In the absence of a suitable animal model, keloid researchers often rely on studying excised keloid scar tissue and keloid-derived cultured cells. Recently, in vivo models have been described that involve transplantation to mice of reconstructed skin containing keloid-derived fibroblasts and/or keratinocytes. These mouse-human hybrid animal models display some similarities with keloids and may enable investigation of novel therapies, although no model yet recapitulates all the features of human keloid scarring. Critical Issues: Differences in skin physiology and modes of healing contribute to challenges in modeling keloids in laboratory animals. Furthermore, recent studies suggest that cells of the immune system contribute to keloid pathology. The need to use immunodeficient hosts for transplanted human keloid cells in recently described animal models precludes studying the role of the immune system in keloid scarring. Future Directions: Future animal models may take advantage of humanized mice with immune systems reconstituted using human immune cells. Such models, when combined with grafted tissues prepared using keloid-derived cells, might enable investigation of complex interactions between systemic and local factors that combine to promote keloid scar formation and may aid in the development of novel therapies. Copyright 2019, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  animal model; extracellular matrix; fibrosis; keloid; scar; wound healing

Year:  2019        PMID: 31832272      PMCID: PMC6906757          DOI: 10.1089/wound.2018.0828

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  9 in total

1.  Effects of Apremilast on Induced Hypertrophic Scar of Rabbits.

Authors:  D Nidhal Ghazy; A Rahmah Abu-Raghif
Journal:  Arch Razi Inst       Date:  2021-12-30

2.  Construction of a HOXA11-AS-Interact Ed Network in Keloid Fibroblasts Using Integrated Bioinformatic Analysis and in Vitro Validation.

Authors:  Qiang Wang; Wei Wang; Xiao-Jie Sun
Journal:  Front Genet       Date:  2022-03-31       Impact factor: 4.772

3.  Experimental Study on Blue Light Interaction with Human Keloid-Derived Fibroblasts.

Authors:  Giada Magni; Martina Banchelli; Federica Cherchi; Elisabetta Coppi; Marco Fraccalvieri; Michele Rossi; Francesca Tatini; Anna Maria Pugliese; Duccio Rossi Degl'Innocenti; Domenico Alfieri; Paolo Matteini; Roberto Pini; Francesco S Pavone; Francesca Rossi
Journal:  Biomedicines       Date:  2020-12-06

4.  Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid.

Authors:  Jiaheng Xie; Liang Chen; Yuan Cao; Dan Wu; Wenwen Xiong; Kai Zhang; Jingping Shi; Ming Wang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

5.  Effect of Mortalin on Scar Formation in Human Dermal Fibroblasts and a Rat Incisional Scar Model.

Authors:  Bok Ki Jung; Tai Suk Roh; Hyun Roh; Ju Hee Lee; Chae-Ok Yun; Won Jai Lee
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

6.  A six-herb Chinese medicine composition ointment as a promising candidate for treatment of hypertrophic scars.

Authors:  Zu-Hua Wang; Xue-Yan Sun; Jiao-Jiao Zhang; Francesca Giampieri; Cheng-Ju Jiang; Ting-Ting Feng; Zhi-Wei Wang; Rong-Yi Chen; Maurizio Battino; Ying Zhou
Journal:  Chin Herb Med       Date:  2020-12-29

7.  TGF-β1 upregulates Sar1a expression and induces procollagen-I secretion in hypertrophic scarring fibroblasts.

Authors:  Keun Jae Ahn; Jun-Sub Kim
Journal:  Open Med (Wars)       Date:  2022-09-17

8.  MicroRNA-21 may be involved in the therapeutic effects of Galla chinensis ointment on keloid.

Authors:  Zhiming Tang; Jicun Ding; Xiaoxiang Zhai; Mengqing Jing; Zhiqiang Guan; Yongcong Li
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

Review 9.  Epigenetic modification mechanisms involved in keloid: current status and prospect.

Authors:  Wenchang Lv; Yuping Ren; Kai Hou; Weijie Hu; Yi Yi; Mingchen Xiong; Min Wu; Yiping Wu; Qi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-26       Impact factor: 6.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.